Independent Director's Work Report for 2025 (Chen Junze)
As an independent director of Zhejiang Taotao Automotive Co., Ltd. (hereinafter referred to as "the Company"), I have strictly adhered to the provisions of the Company Law of the People's Republic of China, the Management Measures for Independent Directors of Listed Companies, the Listing Rules of the Shenzhen Stock Exchange for the Growth Enterprise Market, and the Company's Articles of Association. In my work during 2025, I diligently fulfilled my responsibilities, effectively played the role of an independent director, and attended relevant meetings to carefully review various proposals, legally safeguarding the legitimate rights and interests of the Company and all shareholders. Below is my report on my performance during my term in 2025:
I. Basic Information
(1) Personal Information
Chen Junze, born in 1973, holds a doctoral degree, is a Chinese national, and has no permanent residency abroad. Previously, I served as the Deputy General Manager and General Manager of the Business Department of China Galaxy Securities Co., Ltd., an independent director of Huangshan Jinma Co., Ltd., General Manager of the Business Department and Deputy Director of the Research Institute of Caitong Securities Co., Ltd., Vice President of Zhejiang Equity Service Group Co., Ltd., and Director and General Manager of Zhejiang Zhili Internet Financial Information Service Co., Ltd. From November 2020 to March 2024, I served as Assistant President of Xiangcai Securities Co., Ltd., and from July 2024 to present, I have been Vice President of Zhejiang Equity Service Group Co., Ltd. I have been an independent director of Zhejiang Dongfang Gene Bioproducts Co., Ltd. since November 2025 and an independent director of the Company since October 2024.
(2) Independence Statement
During my tenure as an independent director of the Company, I have not held any position other than that of independent director within the Company, nor have I held any position in the Company's major shareholders. There are no relationships that hinder my ability to make independent and objective judgments, and I meet the independence requirements set forth in the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Normative Operations of Growth Enterprise Market Listed Companies, and the relevant requirements in the Company's Articles of Association and Independent Director Work System.
II. Annual Performance of Independent Directors
(1) Attendance at Board and Shareholder Meetings
During the reporting period, the Company held 8 board meetings and 5 shareholder meetings. As an independent director, I attended all board and shareholder meetings in person, fulfilling my duties and exercising my voting rights without any absences, proxies, or consecutive non-attendance. My attendance record for 2025 is as follows:
| Meeting Type | Total Meetings | Attended | Proxies | Absent | Consecutive Absences |
|---|---|---|---|---|---|
| Board Meetings | 8 | 8 | 0 | 0 | No |
| Shareholder Meetings | 5 | 5 | 0 | 0 | No |
Before the meetings, I obtained relevant materials and information regarding the proposals, carefully reviewed each proposal during the meetings, actively participated in discussions, and made reasonable suggestions, contributing positively to scientific decision-making. In 2025, the convening and holding of board meetings complied with legal procedures, and significant operational decisions and other major matters followed the relevant approval processes, being legal and effective. I voted in favor of all proposals reviewed by the board and did not raise any objections to the proposals or other matters of the Company.